We are live on ! Find out more
SAM

Sectoral Asset Management Portfolio holdings

AUM $121M
1-Year Est. Return 73.47%
This Fund
S&P 500
This Quarter Est. Return
-8.43%
1 Year Est. Return
+73.47%
3 Year Est. Return
+165.77%
5 Year Est. Return
+169.27%
10 Year Est. Return
+1,136.49%
AUM
$514M
AUM Growth
-$86.2M
Cap. Flow
-$11.8M
Cap. Flow %
-2.3%
Top 10 Hldgs %
22.06%
Holding
136
New
15
Increased
60
Reduced
35
Closed
13

Top Buys

Rank Stock Value
1
CNMD icon
CONMED
CNMD
+$7.87M
2
GDRX icon
GoodRx Holdings
GDRX
+$6.71M
3
IOVA icon
Iovance Biotherapeutics
IOVA
+$6.43M
4
ACAD icon
Acadia Pharmaceuticals
ACAD
+$5.7M
5
PODD icon
Insulet
PODD
+$5.42M

Top Sells

Rank Stock Value
1
TMCI icon
Treace Medical Concepts
TMCI
+$9.71M
2
INSP icon
Inspire Medical Systems
INSP
+$7.79M
3
AGTI
Agiliti Inc
AGTI
+$7.74M
4
TVTX icon
Travere Therapeutics
TVTX
+$6.69M
5
AMLX icon
Amylyx Pharmaceuticals
AMLX
+$6.63M

Sector Composition

Rank Sector Weight
1 Healthcare 97.41%
2 Industrials 2.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RCUS icon
26
Arcus Biosciences
RCUS
$3.55B
$6.74M 1.31%
375,456
+20,966
+6% +$421K
ITCI
27
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$6.44M 1.25%
123,680
+3,828
+3% +$223K
PCVX icon
28
Vaxcyte
PCVX
$7.81B
$6.18M 1.2%
121,230
+12,253
+11% +$604K
THC icon
29
Tenet Healthcare
THC
$20.5B
$6.03M 1.17%
91,500
– –
ABBV icon
30
AbbVie
ABBV
$443B
$5.86M 1.14%
39,300
– –
PODD icon
31
Insulet
PODD
$11.5B
$5.86M 1.14%
36,725
+24,225
+194% +$5.42M
GDRX icon
32
GoodRx Holdings
GDRX
$1.04B
$5.67M 1.1%
+1,007,000
New +$6.71M
MRK icon
33
Merck
MRK
$322B
$5.66M 1.1%
55,000
– –
MLTX icon
34
MoonLake Immunotherapeutics
MLTX
$1.57B
$5.58M 1.09%
97,965
-86,625
-47% -$4.78M
HALO icon
35
Halozyme
HALO
$9.79B
$5.58M 1.09%
146,000
+6,563
+5% +$269K
MMSI icon
36
Merit Medical Systems
MMSI
$5.07B
$5.45M 1.06%
79,000
+3,000
+4% +$216K
OLMA icon
37
Olema Pharmaceuticals
OLMA
$1B
$5.41M 1.05%
437,652
-210,701
-32% -$2.15M
DNLI icon
38
Denali Therapeutics
DNLI
$3.65B
$5.26M 1.02%
254,941
+9,650
+4% +$245K
BSX icon
39
Boston Scientific
BSX
$69.5B
$5.23M 1.02%
98,976
– –
PFE icon
40
Pfizer
PFE
$143B
$5.22M 1.02%
157,400
– –
GKOS icon
41
Glaukos
GKOS
$9.83B
$5.19M 1.01%
69,000
– –
ALNY icon
42
Alnylam Pharmaceuticals
ALNY
$27.5B
$5.13M 1%
28,960
-866
-3% -$165K
ABT icon
43
Abbott
ABT
$183B
$5.08M 0.99%
52,498
+2,250
+4% +$236K
LNTH icon
44
Lantheus
LNTH
$6.49B
$4.93M 0.96%
70,987
-27,700
-28% -$2.03M
VERA icon
45
Vera Therapeutics
VERA
$2.3B
$4.9M 0.95%
357,139
+5,493
+2% +$94.2K
BBIO icon
46
BridgeBio Pharma
BBIO
$15.7B
$4.75M 0.93%
+180,195
New +$5.11M
RCKT icon
47
Rocket Pharmaceuticals
RCKT
$340M
$4.65M 0.91%
227,030
+36,240
+19% +$659K
REPL icon
48
Replimune Group
REPL
$941M
$4.64M 0.9%
271,056
+32,515
+14% +$639K
IOVA icon
49
Iovance Biotherapeutics
IOVA
$1.82B
$4.48M 0.87%
+985,000
New +$6.43M
KRTX
50
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$4.39M 0.86%
25,980
+248
+1% +$46.6K
1
2
3 4 5

Similar funds

RIP
Reliant Investment Partners Pinehurst, North Carolina $121M AUM 34.77% 1-Year Est. Return
LFWA
LiftPoint Family Wealth Advisors Far Hills, New Jersey $121M AUM
CF
Conquis Financial Milbrae, California $121M AUM 16.22% 1-Year Est. Return
WIM
Wiregrass Investment Management Thomasville, Georgia $121M AUM
MW
Merited Wealth North Bay Village, Florida $121M AUM
AFC
Avise Financial Cooperative Los Angeles, California $121M AUM
AAA
AG Asset Advisory Los Angeles, California $121M AUM 10.78% 1-Year Est. Return
TGM
Tenzing Global Management San Francisco, California $121M AUM 85.62% 1-Year Est. Return

Sectoral Asset Management's Q3 2023 Portfolio in Review

As of Q3 2023, Sectoral Asset Management held 136 positions worth $514M, down 14% from $600M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Sectoral Asset Management's Q3 2023 filing shows 15 new, 60 increased, 35 reduced and 13 closed positions. Its largest new stake was GoodRx Holdings: 1,007,000 shares worth $5.67M. The largest sale was Treace Medical Concepts, an estimated $9.71M.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, up from 96% a quarter earlier, followed by Industrials.

  • Sectoral Asset Management's largest Q3 2023 buy was GoodRx Holdings: 1,007,000 shares worth $5.67M.
  • Sectoral Asset Management added most to CONMED in Q3 2023, an estimated $7.87M increase.
  • Sectoral Asset Management's biggest Q3 2023 reduction was Amylyx Pharmaceuticals, cutting an estimated $6.63M.
  • Sectoral Asset Management fully exited Treace Medical Concepts in Q3 2023, selling an estimated $9.71M.
  • Sectoral Asset Management's ten largest holdings make up 22% of its $514M portfolio in Q3 2023.
  • Sectoral Asset Management opened 15 new positions and closed 13 in Q3 2023.
  • Sectoral Asset Management's portfolio value fell 14% quarter-over-quarter to $514M.

Based on Sectoral Asset Management's 13F filing for Q3 2023, filed 14 Nov 2023.